BACKGROUND: Ventilation in response to hypoxia is reduced in some obese humans and is believed to represent part of the pathogenesis of obesity hypoventilation syndrome (OHS). Ventilation in response to hypoxic exposure is closely related to the release of excitatory neurotransmitters, in particular glutamate, acting speci®cally on N-methyl-D-aspartate (NMDA) receptors. OBJECTIVES: The aim of the present study was to investigate whether NMDA receptor-mediated mechanisms are responsible for the altered ventilatory response to sustained hypoxia observed in obese Zucker (Z) rats. SUBJECTS: Seven lean and seven 15-week-old obese male Z rats were studied. MEASUREMENTS: Ventilation (V Ç E ) at rest and during 30 min sustained hypoxic (10% O 2 ) exposure was measured by the barometric method. V Ç E was assessed following the blinded-random administration of equal volumes of either saline (vehicle) or dextromethorphan (DM, 10 mgakg), a non-competitive glutamate NMDA receptor antagonist. RESULTS: DM had no effects on resting V Ç E in both lean and obese rats during room air breathing. Lean rats treated with DM exhibited a signi®cant (P`0.05) depression in V Ç E , V T , and V T aT I during either the early (5 min) or the late phase (30 min) of ventilatory response to sustained hypoxia. In contrast, DM administration in obese rats did not change V Ç E , V T , or V T aT I during the early phase of ventilatory response to hypoxia. During the late phase of ventilatory response to hypoxia. obese rats treated with DM exhibited a similar depression in V Ç E and V T as observed in lean rats, but had no signi®cant change in V T aT I during the 30 min hypoxic exposure. CONCLUSION: Our ®ndings indicate that altered glutamatergic mechanisms acting on NMDA receptors are partially responsible for a blunted early phase of ventilatory response to hypoxia noted in obese rats and also contribute to their reduced neural respiratory drive.
Introduction
Obesity increases the demands placed on the respiratory system. Unfortunately, obesity is often associated with compromised respiratory functions and de®cits. 1 Obese Zucker (Z) rats present many of the same respiratory de®cits as described in obese humans, including reduced lung functions, increased chest wall limitations, and blunted ventilatory responses to hypoxia and hypercapnia. 1 ± 4 Reduced pulmonary ventilation during hypoxic and hypercapnic exposures is exhibited by some obese humans and by obese Z rats.
1,4 ± 7 The underlying mechanisms responsible for the blunted ventilatory responses in obesity are unknown, but thought to represent part of pathogenesis of obesity hypoventilation syndrome (OHS) in obese humans. 8, 9 The ventilatory response to sustained hypoxia in humans and in some animals is characterized by an initial increase in ventilation (early phase), followed by a gradual decline in ventilation (late phase). 10, 11 The increase in ventilation during hypoxia is closely related to the release of excitatory neurotransmitters, in particular glutamate, 11 ± 15 acting on Nmethyl-D-aspartate (NMDA) receptors located in brainstem respiratory motor neurons. 11 ± 14 Indeed, blocking NMDA receptors attenuates both the early and the late phases of ventilatory response to sustained hypoxia in conscious animals. mechanisms acting via NMDA receptors are partly responsible for the early and late phases of ventilatory response to hypoxia. 11 ± 15 Whether the altered ventilatory response to hypoxia observed in obese Z rats is associated with altered glutamatergic NMDA function has not been previously studied, and formed the basis of our study. We hypothesized that the altered ventilatory response to hypoxia in obese Z rats is mediated in part via altered glutamatergic NMDA function. We used dextromethorphan (DM), a noncompetitive NMDA receptor antagonist, 16, 17 to investigate whether endogenous glutamate modulates ventilation at rest and ventilation during hypoxic exposure in obese Z rats. A parallel study design was used, with lean age-matched Z rats serving as controls.
Methods

Animals
The studies were performed on seven lean (Faa?) and seven obese (faafa) age-matched 15-week-old male Zucker (Z) rats. Animals were purchased from Vassar College, Poughkeepsie, NY at 4 weeks of age. One lean and one obese rat were housed per cage. Ambient temperature was maintained at 21 C, and an arti®cial 12 h light ± dark cycle was set. The light period began at 7:00 am. Rats were provided with standard laboratory chow (Ralston Purina, St Louis, MO) and water ad libitum. All protocols were approved by the Institutional Animal Care and Use Committee of the University at Buffalo.
Pulmonary ventilation
Breathing pattern was recorded by the barometric technique of plethysmography. 5, 18 A cylindrical plexiglas chamber with a volume of 4 l was used for the measurement of breathing pattern. The rat was placed in the chamber within a restrainer, which did not allow backward rotation. A¯ow of gas through the chamber was provided by either a wall-mounted compressed air source (during the preliminary habituation period) or from pressurized gas tanks (BOC Gases). Inlet¯ow was regulated by a¯owmeter (Dwyer Instruments Inc., Michigan City, IN) and maintained steady at 1.5 lamin during measurement of gas exchange, but raised to 4 lamin for a few minutes to aid wash-in at the time of change-over from room air to the hypoxic gas mixture. The chamber was completely sealed after momentarily interrupting the¯ow through it, and the oscillations in pressure caused by breathing were recorded by a sensitive pressure transducer (Model PT5. Grass Instrument, Quincy, MA). The signal was received and ampli®ed by a Grass DC Driver (model 7PCPA, Grass Instrument) and displayed on an oscillographic strip chart recorder (model 7 polygraph, Grass Instruments). An average of 100 breaths was recorded on chart paper at a speed of 10 mmas. Injection and withdrawal of 0.3 ml volumes were performed at least 12 times during the recording, for calibration purposes. Barometric pressure to the nearest hour was obtained from the Internet posting of the US weather bureau located at the Buffalo International Airport.
From the pressure oscillations due to breathing, tidal volume (V T ) was computed by using the formula of Drorbaugh and Fenn, 19 incorporating the analytical modi®cation suggested by Jacky. 20 For each condition, the average V T and breathing frequency ( f ) and breathing duration per breath (T TOT ) were calculated over a period corresponding to at least 30 successive breaths and the inspiratory fraction of respiratory cycle (T I aT TOT ) were calculated over a period corresponding to 10 successive breaths. The inspiratory duration (T I ) and expiratory duration (T E ) were transformed by T I aT TOT and T TOT (T I T I aT TOT ÂT TOT ; T E T TOT 7 T I ). Pulmonary ventilation (V Ç E ) was also calculated (V Ç E V T Âf ) and neural respiratory drive was assessed as the mean inspiratory¯ow (V T aT I ). For the study, ventilation and tidal volume were always normalized by body weight, body temperature standard pressure under water saturated conditions (BTPS), and expressed in ml BTPS kg 71 min 71 for V Ç E and in ml BTPS kg 71 for V T . Colonic temperature was measured continuously from a rectal probe (Tele-thermometer, Yellow Springs Instruments. Yellow Springs. OH) placed at least 5 cm into the rectum, and taken as representative of body temperature (T b ). Chamber temperature and humidity were monitored by means of a¯ow-through probe (Fisher Scienti®c, Pittsburgh, PA) permanently mounted within the chamber.
Oxygen consumption and CO 2 production Oxygen consumption and CO 2 production were also measured in the barometric chamber. The concentrations of CO 2 and O 2 entering and exiting the barometric chamber were monitored with a CO 2 gas analyzer (Model CD-3A, Amatek Applied Electrochemistry, Sunnyvale. CA) and an O 2 analyzer (model S-3Aal; Amatek Applied Electrochemistry) arranged in series. The calibrations and linearities of the gas analyzers were checked twice daily, using certi®ed calibration gases (BOC gases). Oxygen consumption (V Ç O 2 ) and carbon dioxide production (V Ç CO 2 ) was calculated from the difference between O 2 and CO 2 in¯ow and out¯ow multiplied by the gas¯ow, neglecting the small error introduced by the respiratory quotient less than unity. 21 Data are presented at standard temperature and pressure under dry conditions (STPD), corrected for the effective body mass and expressed in kilograms (kg) to the power of 0.75 (ml O 2 STPD kg 0.75 min 71 ). 22 Effective body mass (EBM) was calculated as 1.00 M 0.75 and 0.86 M 0.75 for lean and obese animals respectively. 22 EBM was used to minimize differences in adipose tissues between lean and obese rats.
Experimental protocol
Animals were tested following a sub-cutaneous (s.c.) injection of an equal volume of either vehicle (saline, 2 mlakg) NMDA modulation of ventilation in obesity SD Lee et al or dextromethorphan (DM, 10 mgakg, dextromethorphan bromide; Sigma Chemical). We selected the 10 mgakg dose of DM based on pilot data in Z rats, noting that the hypoxic responses in lean Z rats at 10 mgakg DM were similar to published responses obtained with various NMDA receptor antagonists in a variety of species. 11 ± 13 Doses of 20, 40 and 80 mgakg were used in pilot studies, and produced the same trend as noted with 10 mgakg and did not further depress V E during hypoxic exposure. We elected to administer DM subcutaneously as this route has been shown to be associated with the least amount of metabolite formation and with DM concentrations about 10-fold higher in the brain than in the plasma. 23 Control (saline) and DM solutions were prepared daily and placed in vials labeled as solutions I or II. The agents were given in a randomized order on two separate occasions with 72 h elapsing between successive tests. The investigators involved in the actual testing remained blinded to the contents of the vials until the ventilatory tests were completed and analyzed. After injection, the rat was placed into the chamber and exposed to room air (21% O 2 , balance N 2 ) for 30 min, then switched to hypoxia (10% O 2 , balance N 2 ) for an additional 30 min. Ventilatory pattern during room air was measured during the last minute of room air and hypoxic ventilatory response was measured at 5, 10, 20 and 30 min. All studies were completed within a 7 day period. In an attempt to minimize any stress during the study, all animals were habituated for 60 min to con®nement on ®ve separate occasions prior to start of the study. To minimize any potential differences due to circadian rhythms, each rat was injected and tested at the exact same time of day.
Statistical analysis
All parameters were analyzed using the general linear model (GLM) analysis of various method in a one-between (lean and obese) and two-within (gases exposures over time, drugs) design. Body weights of individual rats were averaged over the 7-day experimental period and differences between lean and obese groups were tested by unpaired t-test. The difference of ventilatory and metabolic parameters (V Ç E , V T , f, V T aT I , T I aT TOT , T I , T E , V Ç O 2 , V Ç CO 2 and T b ) between dextromethophan (DM) and vehicle were subsequently tested as a single group repeated measure with contrast transformation during room air and during hypoxic exposure in lean and obese rats, separately. The contrast transformation is useful when one level of the repeated measures effect is a control level, saline, against which the other level, DM, is compared. In all cases, a difference at P`0.05 was considered statistically signi®cant. All data presented in the text, tables, and ®gures are means AE s.e.m.
Results
Obese Z rats weighed approximately 34% more than agematched lean rats (455 AE 13 vs 340 AE 10 g, P`0.001; unpaired t-test). Ventilation (V Ç E ) in lean and obese animals breathing room air and 10% O 2 exposure for 30 min is shown in Figure 1 . There was a signi®cant difference in the overall time-dependent change in V Ç E between lean and obese rats (P`0.001; ANOVA). A signi®cant interaction between phenotypes and hypoxic exposures was noted for ventilation (P`0.01; ANOVA). Lean rats exhibited an abrupt increase of V Ç E in response to 5 min hypoxia followed by a gradual decline with sustained hypoxia at 10, 20 and 30 min. In contrast, obese Z rats displayed an initial increase in V Ç E that plateaued with sustained hypoxic exposure. The altered pattern of ventilatory response to hypoxia between lean and obese is shown in Figure 1 . There was a signi®cant interaction among three factors (phenotypes, time courses, and drugs, P`0.01, ANOVA). Therefore, the effect of dextromethorphan (DM) was analyzed as a single group (lean or obese) at each time point (resting ventilation and 5, 10, 20 and 30 min hypoxic exposures).
Resting ventilation
During room air, dextromethorphan (DM) administration did not signi®cantly affect resting minute ventilation (V Ç E ), tidal volume (V T ), breathing frequency ( f ), inspiratory fraction of respiratory cycle (T I aT TOT ) inspiratory duration (T I ), expiratory duration (T E ), oxygen consumption (V Ç O 2 ), carbon dioxide production (V Ç CO 2 ), and body temperature (Tb) in either lean or obese Z rats (Table 1, Figure 2 ). 
NMDA modulation of ventilation in obesity SD Lee et al
Early phase DM administration in lean rats was associated with a signi®cant (P`0.05: repeated measures with contrast transformation) depression in V Ç E , V T , and V T aT I during the early (5 min) hypoxic response relative to saline (Table 2, Figure 2 ). In contrast, obese rats treated with DM did not exhibit Figure 2 ). The response to DM infusion in both lean and obese rats at 5 min hypoxia is shown in Table 2 . The decreased V T was noted in all seven lean rats while the decrease in V Ç E at 5 min hypoxia was observed in six of seven lean rats, whereas V E , V T , or V T aT I was not reduced in obese rats ( Figure 3 ). Other parameters, ie f, T I aT TOT , T I , T E , V Ç O 2 , V Ç CO 2 and T b , were not affected by DM administration during the early phase (5 min) of ventilatory response to hypoxia in either lean or obese rats (Table 2) .
Late phase
During the late phase of ventilatory response to hypoxia, lean rats treated with DM exhibited a signi®cant (P`0.05) depression in V Ç E , V T and V T aT I at 10, 20 and 30 min relative to saline, with the exception of V Ç E at 10 min (Table 3 , Figure  2 ). Obese rats exhibited a signi®cant (P`0.05) depression in V Ç E at 20 and 30 min ( Figure 2B ) and V T at 20 min relative to saline following DM administration. Thus, although it would appear that a similar response of ventilation (V Ç E ) to hypoxia was noted during late phase in obese and in lean rats (Figure NMDA modulation of ventilation in obesity SD Lee et al 2) in contrast to lean rats, obese rats did not signi®cantly change neural respiratory drive (V T aT I ) after DM administration ( Figure 2) . Tb, f, T I aT TOT , T I , T E , V Ç O 2 and V Ç CO 2 were unchanged during the late phase of ventilatory response to hypoxia following DM administration in both lean and obese rats (Table 3 ).
Discussion
Our ®ndings can be summarized as follows: (1) dextromethorphan (DM) administration does not alter resting metabolism and ventilation in lean or obese male Z rats; (2) during the early phase of hypoxic exposure, ventilation appears to be modulated by NMDA receptors in lean, but not obese, Z rats; (3) ventilation during the late phase of hypoxic exposure is depressed by NMDA receptor antagonism in both lean and obese rats, although the neural respiratory drive (V T aT I ) during the late phase is modulated by NMDA receptors in lean, but not in obese rats. Glutamate, an excitatory neurotransmitter, has an important role in the central mechanisms of respiratory control. 14,24 ± 26 Glutamate activates ionotropic NMDA (N-methyl-D-aspartate) and non-NMDA (AMPA and kainate) receptors, as well as metabotropic receptors, all of which have been shown to be involved in the generation, the transmission, and the modulation of respiratory neural activity. 14, 25, 26 We speci®cally investigated the respiratory modulation of NMDA receptors in obesity. Dextromethorphan (DM), a NMDA receptor antagonist, was injected systemically with a widespread antagonistic action. Thus, any effect noted herein cannot be localized to any speci®c system or brain region. The goal of the present study, however, was to determine whether NMDA mechanisms are responsible for the altered ventilatory pattern adopted by obese Z rats.
Clearly, additional experiments using microinjections into speci®c brain regions will be required to identify those areas that are directly responsible for the ventilatory responses described below.
The most common noncompetitive NMDA receptor antagonist used in ventilatory studies is dizocilpine (MK-801). 12, 13, 24, 27 For the current study, however, we selected dextromethorphan (DM) over MK-801 because preliminary studies in our lab demonstrated that low doses of MK-801 (0.1 ± 0.5 mgakg, i.p.) produced restlessness and hyperlocomotion in Z rats, while higher doses of MK-801 (1 ± 5 mgakg, i.p.) produced motor impairments (myorelaxationaataxia) and excessive salivation (unpublished observations). Those side effects have been previously reported in rodents, but at higher doses. 28, 29 We concluded from our pilot work that MK-801 was extremely toxic for Z rats, and excluded MK-801 as a potential NMDA receptor antagonist for our studies. Dextromethorphan (DM), on the other hand, is a widely used antitussive agent, which has been found to also be an allosteric NMDA receptor antagonist species. 16, 17, 23, 30, 31 Cannoll et al observed that DM acts on receptors in brain stem regions, including the nucleus of the solitary tract, the nucleus ambiguus, and hypoglossal nuclei, 32 all with links to ventilatory control. 26 In the present studies, DM administration in Z rats did not produce any of the side effects that were observed with MK-801. Since DM has been shown to have safer and lower toxicological effects in other species compared to MK-801, 23, 30 and from our own preliminary observations in Z rats, DM was deemed a suitable agent. In the present study, the ventilatory response to hypoxia noted at a dose of 10 mgakg DM in lean Z rats was similar to responses obtained with other NMDA receptor antagonists in piglets, 11 in dogs 12 and in rats. 13, 24 Resting ventilation In the present study, baseline (saline) ventilatory and metabolic variables (Table 1) for both lean and obese rats were within the range of previously published values. 5, 18 The primary purpose of the current study, however, was to assess the role of NMDA receptors in modulating ventilation. Thus, lean and obese rats were used as their own control such that weight differences between both phenotypes cannot account for our ®nding in NMDA receptor-mediated modulation. As expected, DM administration had no effects at rest in both lean and obese Z rats. These ®ndings are in agreement with previous studies noting that NMDA antagonists have no effects on f, V T , V E and V O 2 under normoxic condition in conscious animals.
11,31
Ventilatory response to hypoxia Lean Z rats exhibited an abrupt increase in ventilation in response to hypoxia (early phase) followed by a gradual decline with sustained hypoxia (late phase). Obese Z rats, however, displayed a smaller initial increase in ventilation in response to hypoxia that plateaued with sustained hypoxic exposure. This decreased initial response to hypoxia supports ®ndings in a previous study. 4 The initial rise in ventilatory response to acute hypoxia is a response originating from peripheral afferent discharge, arising mainly from the carotid body. The afferent inputs from carotid sinus nerve project to the glutamatergic synapses in the nucleus tractus solitarius (NTS), which leads to release of glutamate centrally. 13 The increased glutamate increases the activity of NMDA and non-NMDA receptors in brainstem respiratory motor neurons, thus increasing the level of ventilation. 13, 14, 24 Indeed, glutamate levels are elevated in the NTS and the medulla during brief hypoxic challenges. 14, 15, 27 Therefore, the altered pattern of ventilatory response to hypoxia in obese Z rats is suggestive of an altered NMDA receptor mediated mechanism.
Lean rats treated with DM have depressed V Ç E relative to saline not only during the early hypoxic response but also during the late hypoxic response, which suggests that endogenously released glutamate modulate both the early and late phase of hypoxic responses in part through NMDA receptors. The decreased ventilation was not related to metabolic rate or body temperature, since DM had no effect on either V Ç O 2 or T b in lean rats (Table 2 ). This is in agreement with previous reports demonstrating that the application of NMDA blockers decreased both the early and late phase of ventilatory response to hypoxia in unanesthetized piglets 11 and eliminated overall phrenic nerve output during 30 min hypoxia in anesthetized rats. 24 In contrast, DM in obese Z rats did not affect V Ç E during the early phase of ventilatory response to hypoxia but depressed V Ç E during the late phase of ventilatory response to hypoxia. The early response therefore is modulated by NMDA receptor-mediated mechanisms in lean Z rats, whereas it is not in obese Z rats.
The mechanisms responsible for lack of a decline in ventilation during the late phase in the obese rats is dif®cult to determine in light of the current ®ndings and will require additional studies, such as denervation of carotid sinus nerve, or real-time microdialysis of neurotransmitters in CNS. Although ventilation during the late response to hypoxia appears to be depressed following DM in both lean and obese rats, the underlying mechanisms in neural respiratory drive (V T aT I ) during either the early or late phase of ventilatory response to hypoxia is appreciably different. The depressed V Ç E affected by DM in lean rats may be mediated by decreased neural respiratory drive whereas reduced V Ç E in obese rats during the late phase of ventilatory response to hypoxia is not (Table 3) . Additional studies, however, will be required to address the mechanisms responsible for the blunted NMDA-mediated neural respiratory drive during ventilatory response to hypoxia in obese Z rats, which could include blunted peripheral afferents, insuf®cient central glutamate releases, or altered NMDA receptors in speci®c central location after hypoxic exposure.
Signi®cance
Obese humans are often noted to have a depressed ventilatory response to hypoxia, which is thought to represent part of the pathogenesis of obese hypoventilation syndrome (OHS). 8, 9 The development of OHS is insidious and is often overlooked because patients are typically free of respiratory complaints. Since altered NMDA receptor mediated mechanisms partially contribute to a ventilatory response to hypoxia during early phase of hypoxic exposure and to a blunted neural respiratory drive during hypoxic exposure in obese Z rats, it is possible that altered NMDA receptor-mediated activity may represent a neural component of OHS in morbidly obese humans.
